ROKIT HEALTHCARE Inc. Logo

ROKIT HEALTHCARE Inc.

Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.

376900 | KO

Overview

Corporate Details

ISIN(s):
KR7376900007
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로10길 9, 12층, 서울특별시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

ROKIT HEALTHCARE Inc. is a biotechnology company specializing in hyper-personalized organ regeneration and regenerative medicine. Established in 2012, the company develops and commercializes advanced healthcare solutions centered on its proprietary 3D and 4D bioprinting technologies, specialized bioinks, and AI-driven platforms. Its primary focus is on providing effective treatments for chronic conditions, such as diabetic foot ulcers and skin ailments, by shifting the treatment paradigm from conventional surgery to autologous organ regeneration. The company has secured patents for its innovative multi-organ bioprinting technology, aiming to offer safer and more effective therapeutic options worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 48.9 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.8 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정 (임시주주총회)
Korean 4.3 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-18 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-07-16 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 72.0 KB
2025-05-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 118.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB

Automate Your Workflow. Get a real-time feed of all ROKIT HEALTHCARE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ROKIT HEALTHCARE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ROKIT HEALTHCARE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Terns Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing small-molecule drugs for oncology & metabolic diseases.
United States of America
TERN
Tevogen Bio Holdings Inc. Logo
Developing precision, off-the-shelf T cell therapies for cancer, infections, and neuro disorders.
United States of America
TVGN
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom
TCF
Theriva Biologics, Inc. Logo
Develops systemic oncolytic virus therapies to selectively destroy difficult-to-treat cancers.
United States of America
TOVX
Thirdeye Systems Ltd. Logo
Develops AI-driven thermal/visual perception solutions for defense, security & autonomous systems.
Israel
THES
TiumBio Co., Ltd. Logo
Clinical-stage biopharma developing therapies for rare diseases, gynecology, and hemophilia.
South Korea
321550
Tiziana Life Sciences Ltd Logo
Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.
United States of America
TLSA
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden
TOL
ToolGen Incorporated Logo
A biotech firm licensing genome editing patents for therapeutics and agriculture.
South Korea
199800
Transcode Therapeutics, Inc. Logo
Develops targeted RNA therapies for metastatic cancer using a proprietary nanoparticle delivery platform.
United States of America
RNAZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.